Raaj Medisafe Complete Financial Statements
In FYNone, Raaj Medisafe (RAAJMEDI) reported revenue ₹94 Cr, net profit ₹2 Cr and EPS ₹2.00, with a net profit margin of 2.5% and ROE of 4.3%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Raaj Medisafe share price chart.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
RAAJMEDI Revenue, Net Profit & EBITDA — Year-on-Year Growth
RAAJMEDI YoY (March 2026 vs Period) — revenue +16.0%, EBITDA +16.7%, expenses +19.1%.
RAAJMEDI Income Statement — Revenue, EBITDA & Net Profit
Raaj Medisafe revenue ₹94 Cr, EBITDA ₹14 Cr, net profit ₹2 Cr, EPS ₹2.00 (None) — net profit margin 2.5%. Compare with RAAJMEDI fundamental valuation to assess whether the stock is under or overvalued.
| Particulars | None | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 94 | 81 | 63 | 43 | 39 | 35 | 32 | 22 | 5 | 5 | 5 | 2 | 0 |
| Expenses | 81 | 68 | 54 | 37 | 33 | 30 | 28 | 20 | 6 | 5 | 5 | 2 | 1 |
| EBITDA | 14 | 12 | 9 | 7 | 6 | 5 | 4 | 2 | -1 | -1 | 0 | 0 | -1 |
| Operating Profit Margin % | 14.00% | 15.00% | 14.00% | 15.00% | 15.00% | 15.00% | 13.00% | 7.00% | -16.00% | -10.00% | -2.00% | -17.00% | -14441.00% |
| Depreciation | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Interest | 4 | 4 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Profit Before Tax | 8 | 6 | 5 | 4 | 4 | 4 | 3 | 0 | -2 | -1 | -1 | -1 | -1 |
| Tax | 2 | 5 | -1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 2 | 2 | 6 | 3 | 3 | 3 | 2 | 0 | -2 | -1 | -1 | -1 | -1 |
| Earnings Per Share (₹) | 2.00 | 1.10 | 4.60 | 3.07 | 3.06 | 2.82 | 2.07 | -0.30 | -3.16 | -2.86 | -1.68 | -2.14 | -2.35 |
RAAJMEDI Balance Sheet — Assets, Liabilities & Shareholders' Equity
RAAJMEDI total assets ₹121 Cr, total equity ₹47 Cr, total liabilities ₹ Cr (2026) — ROE 4.3%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 121 | 69 | 41 | 26 | 20 | 17 | 14 | 5 | 5 | 6 | 5 | 4 |
| Current Assets | 51 | 30 | 19 | 15 | 10 | 7 | 6 | 2 | 2 | 2 | 2 | 1 |
| Fixed Assets | 39 | 24 | 11 | 9 | 9 | 7 | 7 | 4 | 4 | 4 | 4 | 3 |
| Capital Work in Progress | 27 | 9 | 10 | 2 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 56 | 37 | 20 | 16 | 10 | 8 | 7 | 2 | 2 | 2 | 2 | 1 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 39 | 14 | 15 | 7 | 6 | 9 | 8 | 10 | 8 | 8 | 7 | 7 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 47 | 27 | 11 | 8 | 4 | 1 | -1 | -8 | -6 | -5 | -4 | -3 |
| Share Capital | 16 | 13 | 11 | 11 | 11 | 11 | 11 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 30 | 14 | 0 | -3 | -7 | -10 | -12 | -13 | -11 | -10 | -9 | -8 |
RAAJMEDI Cash Flow Statement — Operating, Investing & Financing
Raaj Medisafe operating cash flow ₹4 Cr, investing ₹-35 Cr, financing ₹44 Cr, net cash flow ₹13 Cr (2026).
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 4 | 0 | 4 | 0 | 3 | 2 | -1 | -1 | 0 | 0 | 0 | 0 |
| Investing Activities | -35 | -16 | -13 | -2 | -1 | -3 | 0 | 0 | 0 | -1 | -1 | -2 |
| Financing Activities | 44 | 17 | 9 | 2 | -2 | 1 | 1 | 1 | 0 | 1 | 0 | 3 |
| Net Cash Flow | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |